Bifidobacterium longum on the European supplement market
Most ingredient pages tell you what Bifidobacterium longum is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 112 Bifidobacterium longum products from 55 brands across the EU and US. 0 brands advertise it on Meta right now, and new-ad activity held roughly steady in the last 30 days. Germany shows the heaviest advertising, while Germany has the largest shelf. The median EU shelf price sits around €36.
How brands use Bifidobacterium longum, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 26 | 11 | — | — | €48.88 |
| United Kingdom | 8 | 5 | — | — | £21.66 |
| France | 15 | 4 | — | — | €56.95 |
| Italy | 5 | 5 | — | — | €26.00 |
| Spain | 7 | 4 | — | — | €23.56 |
| Romania | 6 | 5 | — | — | 98.50 RON |
| United States | 12 | 6 | — | — | $29.49 |
| Austria | 2 | 2 | — | — | — |
Who is on the shelf right now
Top brands by number of Bifidobacterium longum products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| Bifidobacterium longum ssp. infantis | 79 |
| Bifidobacterium longum subsp. infantis (strain Bi-26) | 23 |
| Bifidobacterium infantis | 2 |
| Bifidobacterium longum ssp. infantis (strain BI45) | 2 |
| Bifidobacterium longum ssp. infantis | 2 |
| Bifidobacterium longum ssp. infantis (strain BI02) | 1 |
Regulatory & positioning
| Botanical source | Bifidobacterium longum ssp. infantis |
|---|---|
| Novel food status | — |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | gut health, immunity, kids |
No EFSA-authorized health claim exists for Bifidobacterium longum, yet brands market it for gut health, immunity, kids — the gap between claim and positioning is itself a competitive signal.
Where Bifidobacterium longum shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is Bifidobacterium longum?
Bifidobacterium longum ssp. infantis is a probiotic strain belonging to the Bifidobacterium genus. It is commonly included in dietary supplements formulated for gut health, immunity, and pediatric use. This microorganism is often found in products targeting digestive balance and immune system support, particularly in formulations designed for children. As a probiotic, it is used to complement the gut microbiota and is incorporated into various supplement formats such as capsules, powders, and chewables.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access